Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
BBS21 is an autosomal recessive ciliopathy characterized by obesity, postaxial polydactyly, retinal degeneration, and mild cognitive impairment ({1:Heon et al., 2016}; {2:Khan et al., 2016}).nnFor a general phenotypic description and a discussion of genetic heterogeneity of Bardet-Biedl syndrome, see BBS1 (OMIM:209900).
Features include: Constriction of peripheral visual field, Abnormality of the dentition, Delayed speech and language development, and Hyperautofluorescent macular lesion and 14 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 4 | Hyperautofluorescent macular lesion, Retinal thinning on OCT, Blindness |
CFAP418 encodes cilia and flagella associated protein 418 (207 aa). May be involved in photoreceptor outer segment disk morphogenesis Highest expression in Ovary (7.0 TPM) and Uterus (5.2 TPM).
Bardet-biedl syndrome 21 is associated with mutations in the CFAP418 gene on chromosome 8.
CFAP418 is classified as a druggable target with score 0.0.
Genetic testing for CFAP418 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for bardet-biedl syndrome 21 has been reported in the published literature.
No clinical trials have been registered for bardet-biedl syndrome 21.
14 publications have been identified in PubMed for bardet-biedl syndrome 21. Research spans Epidemiology / Natural History (50%), Case Report / Case Series (29%), and Diagnostic / Biomarker (7%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 7 | 50% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Brain and nerves
1 |
Delayed speech and language development |
Arms and legs | 1 | Postaxial hand polydactyly |
Kidneys and urinary system | 1 | Horseshoe kidney |
Digestive system | 1 | Elevated circulating hepatic transaminase concentration |
Lab test results | 1 | Elevated circulating hepatic transaminase concentration |
Muscles | 1 | Retinal atrophy |
Patient case studies
4 |
29% |
Testing and diagnosis research | 1 | 7% |
Clinical study results | 1 | 7% |
Laboratory research | 1 | 7% |
Romo-Aguas JC (2026). [PMID: 42022048](https://pubmed.ncbi.nlm.nih.gov/42022048/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Varughese RS (2026). [PMID: 42044156](https://pubmed.ncbi.nlm.nih.gov/42044156/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Aziz A (2026). [PMID: 41832542](https://pubmed.ncbi.nlm.nih.gov/41832542/). *J Med Case Rep*. [Case Report / Case Series]
Bouchoual M (2025). [PMID: 40852023](https://pubmed.ncbi.nlm.nih.gov/40852023/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Guo Z (2025). [PMID: 41331888](https://pubmed.ncbi.nlm.nih.gov/41331888/). *Zhonghua Wei Zhong Bing Ji Jiu Yi Xue*. [Epidemiology / Natural History]
Murati Calderon RA (2025). [PMID: 40718228](https://pubmed.ncbi.nlm.nih.gov/40718228/). *Cureus*. [Epidemiology / Natural History]
AbouZeid AA (2025). [PMID: 40340192](https://pubmed.ncbi.nlm.nih.gov/40340192/). *J Pediatr Urol*. [Case Report / Case Series]
Hui H (2025). [PMID: 40329189](https://pubmed.ncbi.nlm.nih.gov/40329189/). *BMC Pediatr*. [Epidemiology / Natural History]
Pomeroy J (2025). [PMID: 40847358](https://pubmed.ncbi.nlm.nih.gov/40847358/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Piekarska K (2025). [PMID: 41465080](https://pubmed.ncbi.nlm.nih.gov/41465080/). *Genes (Basel)*. [Case Report / Case Series]